Earlier this month, Dexcom shared compelling new details on its longer-wear, less calibration G6 sensor and its partnership with Verily to develop a bandage-like continuous glucose monitoring (CGM) device. The G6 sensor is expected to launch in 2018, while the first-gen Verily sensor will launch in late 2018, with a second-gen version coming as early […]
You know why they won’t tell you about that one exercise trick to cut your insulin needs in half? Because there isn’t one. If you’re reading this, then you most likely chose to take a look at a health article that sounded too good to be true before sharing it or reacting to it on […]
We recently received an order of Medtronic/BD’s new MiniMed Pro-Set with FlowSmart technology, a little over a week after the initial limited launch began in the US (At this time, Medtronic is no longer accepting new participation in the limited launch; a full rollout is expected in early 2017, according to BD’s recent company update).
People with diabetes mellitus may be at increased risk for cognitive decline. Correlating these findings with activities of daily living and with degree of DM control is needed, but this study provides further evidence that treating DM may decrease the burden of cognitive decline in older adults.
The maker of inhaled insulin Afrezza is betting that relaunching their product and making it a success depends less on diabetics being afraid of needles and more on its clinical advantages over existing insulin.
If you’re like nearly one-third of Americans over age 40, you probably take a statin. These cholesterol-lowering drugs are used for reducing risk of stroke and heart attack. They work by lowering the amount of LDL cholesterol, the so-called “bad cholesterol” in the blood. Statins also reduce inflammation around plaque in the blood vessels.
More than 29 million people in the U.S., or 9.3 percent of the population, have diabetes, with 1.7 million people ages 20 years or older diagnosed in 2012 alone, according to the Centers for Disease Control and Prevention (CDC).
Many in the Type 1 diabetes community wish for two things: lower insulin prices and non-injectable insulin. Now, there’s evidence that the former may have killed off the latter. According to a Fierce Biotech report, Novo Nordisk announced in an October 31st earnings call that it is halting research and development efforts aimed at creating […]
On World Diabetes Day, a consortium of international medical organizations is highlighting the fact that a quarter of people with diabetes are not discussing eye complications with their healthcare professional, despite a worldwide survey indicating that vision loss is feared twice as much as other common complications of diabetes.
The researchers found that the risk of cancers of the colon (males only), liver (males only), pancreas, lung (males only), and brain (males only) were increased up to nine-fold for patients treated with insulin or insulin secretagogues; the risk of prostate cancer was decreased strongly. The risks were generally decreased for patients taking statins, with […]
A global study by the International Diabetes Federation (IDF) has found that many patients don’t know they have type 2 diabetes, usually due to lack of early screening. Very few people take adequate treatment, with almost one in two (46 per cent) patients still undiagnosed among the estimated 415 million adults living with diabetes across […]
Erik Vance didn’t go to a doctor until he was 18; he grew up in California in a family that practiced Christian Science. “For the first half of my life, I never questioned the power of God to heal me,” Vance writes in his new book, Suggestible You: Placebos, False Memories, Hypnosis, and the Power […]
With the surprising announcement this month that the FDA had cleared the way for Medtronic’s 670G hybrid system, sometimes referred to as an artificial pancreas, most people with diabetes were swinging their pump tubing with glee or juggling their (safety-capped) syringes in delight. And with good reason. We are on the cusp of a flood […]
Donald Trump’s electoral college win has already had a ripple effect within diabetes care circles. As he’s been putting together an administration, it’s still been hard to predict where his administration will land on issues that affect people with diabetes. Less than a week after the election, already his positions on health care and health […]
High-protein diets may help you lose weight in the short term, but could have negative effects on your health down the road.
The new guidelines, published in Diabetes Care, include suggestions of moderate to intense physical activities, as well as light forms of exercise to cut daily sitting time.
Researchers concluded that telling patients with type 2 diabetes to “Take a short walk right after meals” may be one of the best exercise prescriptions a clinician can give. Results from the randomized crossover study show that post-meal blood glucose levels dropped 12%, on average, when patients with type 2 diabetes walked for 10 minutes […]
Vermont Senator Bernie Sanders and Maryland Representative Elijah Cummings have sent a letter asking the U.S. Department of Justice and the U.S. Federal Trade Commission to open an investigation into whether the three major insulin-manufacturers “have colluded or engaged in anticompetitive behavior in setting their drug prices.”
The type 2 diabetes drug liraglutide could affect heart variability in newly diagnosed people who are overweight and have heart problems, according to new research. Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist which helps control blood sugar levels and reduces post-meal hyperglycemia. The drug is marketed as Victoza and Saxenda.
John Higgins, M.D., associate professor of systems biology at Harvard Medical School in Boston, along with Dr. Roy Malka and David M. Nathan used an algorithm to analyze blood glucose levels through HbA1c testing. “This enabled the scientists to account for variations in the age of blood cells among different people,” Higgins told Diabetes in […]